These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16369774

  • 1. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.
    Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G.
    Diabetologia; 2006 Feb; 49(2):351-9. PubMed ID: 16369774
    [Abstract] [Full Text] [Related]

  • 2. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ, Ong MK, Lutterman JA, Smits P.
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [Abstract] [Full Text] [Related]

  • 3. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML, Widmer B, Dunger DB, Dalton RN.
    Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ.
    J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
    [Abstract] [Full Text] [Related]

  • 5. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans.
    Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G.
    J Clin Invest; 1995 Aug; 96(2):786-92. PubMed ID: 7635973
    [Abstract] [Full Text] [Related]

  • 6. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
    Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G.
    Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
    Türkçüoğlu I, Engin-Üstün Y, Turan F, Kali Z, Karabulut AB, Meydanli M, Kafkasli A.
    Gynecol Endocrinol; 2011 Sep; 27(9):609-14. PubMed ID: 20695761
    [Abstract] [Full Text] [Related]

  • 8. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.
    McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS.
    J Clin Endocrinol Metab; 2006 May; 91(5):1896-900. PubMed ID: 16507636
    [Abstract] [Full Text] [Related]

  • 9. Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease.
    Cetinalp-Demircan P, Can A, Bekpinar S, Unlucerci Y, Orhan Y.
    Endocrine; 2007 Apr; 31(2):100-4. PubMed ID: 17873318
    [Abstract] [Full Text] [Related]

  • 10. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study.
    Karelis AD, Pasternyk SM, Messier L, St-Pierre DH, Lavoie JM, Garrel D, Rabasa-Lhoret R.
    Appl Physiol Nutr Metab; 2007 Dec; 32(6):1089-96. PubMed ID: 18059582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
    Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS.
    JAMA; 2002 Mar 20; 287(11):1420-6. PubMed ID: 11903029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.